The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Alpha particle radium-223 dichloride (223RaCl2 ) in high risk osteosarcoma.
 
Vivek Subbiah
Patents, Royalties, Other Intellectual Property - Novartis, GSK, Nanocarrier, NorthWest Biotherapeutics, Roche/Genentech, BergPharma, Bayer, Incyte, FujiFilm, Pharmamar, D3, Pfizer Amgen, Abbvie, Multivir, BioXcel
 
Peter Meade Anderson
No Relationships to Disclose
 
Kalevi Kairemo
No Relationships to Disclose
 
Winston W. Huh
No Relationships to Disclose
 
Vinod Ravi
No Relationships to Disclose
 
Najat C. Daw
Consulting or Advisory Role - Bayer; Incyte
 
Neeta Somaiah
Honoraria - Immune Design
Travel, Accommodations, Expenses - Immune Design
 
Robert S. Benjamin
Stock and Other Ownership Interests - Express Scripts (I); Gilead Sciences (I); Johnson & Johnson (I); Merck Serono (I); Pfizer (I)
Consulting or Advisory Role - Karyopharm Therapeutics; Lilly; Novartis
Travel, Accommodations, Expenses - PharmaMar
 
David S. Hong
Research Funding - Amgen; AstraZeneca; Daiichi Sankyo; Eisai; Genentech; Lilly; Merck; Mirati Therapeutics; miRNA Therapeutics; Novartis; Pfizer
Travel, Accommodations, Expenses - Loxo; miRNA Therapeutics
 
Gregory Ravizzini
No Relationships to Disclose
 
Eric Rohren
No Relationships to Disclose